Correction: Overall survival of patients with KIT-mutant metastatic GIST in the era of multiple kinase inhibitor availability

J Cancer Res Clin Oncol. 2025 Jan 11;151(1):33. doi: 10.1007/s00432-024-06056-y.

Valerie Haller^{1

2}, Carina Reiff^{1

2}, Rainer Hamacher^{1

2}, Karina Kostbade^{1

2}, Moritz Kaths^{2

3}, Juergen Treckmann^{2

3}, Stefanie Bertram^{2

4}, Yasmin Zaun^{1

2}, Sebastian Bauer^{5

6}, Johanna Falkenhorst^{1

2}

¹ Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Hospital Essen, Essen, Germany.
² German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
³ Department of Visceral and Transplantation Surgery, University Hospital Essen, Essen, Germany.
⁴ Department of Pathology, University Hospital Essen, Essen, Germany.
⁵ Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Hospital Essen, Essen, Germany. sebastian.bauer@uk-essen.de.
⁶ German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany. sebastian.bauer@uk-essen.de.

No abstract available

Publication types